You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Drug Formulary
About the Drug Formulary Email Drug Formulary Team

Financement des régimes fondés sur les données probantes

Les monographies et fiches d’information sur les médicaments et les régimes à l’intention des patients offrent des renseignements sur la posologie et l’administration des traitements contre le cancer.

Elles ne sont fournies qu’à titre indicatif et ne visent pas à remplacer les renseignements posologiques ni les recommandations d’un médecin.

Si vous avez des questions à propos du financement des TS-PBQ, veuillez consulter la Foire aux questions (anglais) de notre site Web.

Découvrez les fiches d’information améliorées sur les régimes à l’intention des patients, élaborées en collaboration avec les conseillers des patients et des familles. Disponible en français.

Regimens

Filtered By:
150 Items
Cancer Type: Lung     
Intent: Neoadjuvant, Adjuvant, Palliative
Drugs Used:
DOXOrubicin,
CISplatin,
vinCRIStine,
cyclophosphamide
... Show more tags
Quick Link(s):
Regimen Monograph
May 2019
Cancer Type: Genitourinary, Testis     
Intent: Adjuvant, Curative
Drugs Used:
bleomycin,
etoposide,
CISplatin
... Show more tags
Quick Link(s):
Regimen Monograph
May 2019
Cancer Type: Genitourinary, Testis     
Intent: Adjuvant, Curative
Drugs Used:
bleomycin,
etoposide,
CISplatin
... Show more tags
Quick Link(s):
Regimen Monograph
May 2019
Cancer Type: Gynecologic, Germ Cell     
Intent: Adjuvant
Drugs Used:
bleomycin,
CISplatin,
etoposide
... Show more tags
Quick Link(s):
Regimen Monograph
May 2019
Cancer Type: Gynecologic, Germ Cell     
Intent: Curative
Drugs Used:
PACLitaxel,
bleomycin,
etoposide,
CISplatin
... Show more tags
Quick Link(s):
Regimen Monograph
May 2019
Cancer Type: Genitourinary, Testis     
Intent: Curative
Drugs Used:
PACLitaxel,
bleomycin,
CISplatin,
etoposide
... Show more tags
Quick Link(s):
Regimen Monograph
May 2019
Cancer Type: Hematologic, Multiple Myeloma     
Intent: Palliative
Funding:
New Drug Funding Program
    Bortezomib - Relapsed or Refractory Multiple Myeloma
New Drug Funding Program
    Daratumumab – In Combination with Bortezomib and Dexamethasone for Relapsed Multiple Myeloma
ODB - General Benefit
    dexamethasone
... Show more tags
Drugs Used:
bortezomib,
daratumumab,
dexamethasone
... Show more tags
Quick Link(s):
Regimen Monograph
Sep 2019
Cancer Type: Hematologic, Myeloproliferative Neoplasms (MPNs)     
Intent: Palliative
Funding:
ODB - General Benefit
    busulfan - oral tablets
... Show more tags
Drugs Used:
busulfan
... Show more tags
Quick Link(s):
Regimen Monograph
May 2019
Cancer Type: Lung, Thymoma     
Intent: Palliative
Drugs Used:
cyclophosphamide,
DOXOrubicin,
CISplatin
... Show more tags
Quick Link(s):
Regimen Monograph
Nov 2017
Cancer Type: Head and Neck     
Intent: Palliative
Drugs Used:
cyclophosphamide,
DOXOrubicin,
CISplatin
... Show more tags
Quick Link(s):
Regimen Monograph
May 2019
Cancer Type: Gastrointestinal, Esophagus, Gastric / Stomach     
Intent: Palliative
Funding:
ODB - General Benefit
    capecitabine
... Show more tags
Drugs Used:
CISplatin,
capecitabine
... Show more tags
Quick Link(s):
Regimen Monograph
May 2019
Cancer Type: Gastrointestinal, Hepatobiliary / Liver / Bile Duct     
Intent: Palliative
Funding:
ODB - General Benefit
    capecitabine
... Show more tags
Drugs Used:
CISplatin,
capecitabine
... Show more tags
Quick Link(s):
Regimen Monograph
May 2019